BREAST CANCER RESEARCH NEWS: WHAT YOU NEED TO KNOW December 2020
Some Older Women With Early-Stage Hormone-Receptor-Positive, Node-Positive Breast Cancer Can Skip Chemotherapy Postmenopausal women diagnosed with early-stage hormone-receptor-positive, HER2-negative breast cancer with one to three positive lymph nodes can safely skip chemotherapy, depending on their Recurrence Score from the Oncotype DX test, which
analyzes genes from a breast cancer tissue sample.
FDA Approves Margenza Plus Chemotherapy for Pretreated Metastatic HER2-Positive Breast Cancer Last week, the FDA approved the targeted therapy Margenza in combination with chemotherapy for people who have been treated previously with two or more anti-HER2 regimens, at least one of which was for metastatic disease. Read
How Vitamins and Other Supplements Interfere With Hormonal Treatments After Breast Cancer In a new study, 80% of the women enrolled were taking a dietary supplement. Dietary supplements are not FDA-regulated and can interact with treatments after cancer. Researchers looked at the most common supplements and potential issues, and
how to better guide people on their usage. Listen
Exercise Plus Mindfulness May Ease Fatigue in Breast Cancer Survivors A combination of exercise and mindfulness training seems better at easing fatigue in breast cancer survivors than either technique alone, according to a small study. Fatigue is the most common side effect of breast cancer treatment, and it can affect people even after treatment ends. Read
Easing Depression in Young Cancer Survivors A new study looked at using mindfulness meditation and survivorship education classes to alleviate depression in women treated for breast cancer who were 50 years of age or younger at the time of diagnosis. Listen
The Breastcancer.org
research news update is sponsored by Lilly Oncology.
